Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

This commentary is provided by the Medical Marijuana Education and Research Initiative (MMERI) of Florida A&M University.

By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...

Some research suggests there is a connection between migraines and multiple sclerosis (MS), as the conditions often co-occur. Further, the symptoms of MS may also be similar to or confused with a ...

Bruton tyrosine kinase (BTK) inhibitors are typically used to treat B-cell malignancies, but they have also recently attracted interest for their potential in treating the autoimmune disorder multiple ...

Selma Blair, who opened up about her diagnosis with multiple sclerosis in 2018, is “truly in remission,” she told People on Thursday, nearly seven years after she went public with her diagnosis.

Assessing multiple sclerosis (MS) disease activity using Octave Bioscience’s MS Disease Activity (MSDA) blood biomarker test can help guide clinicians’ decisions about care, a study showed.

With the right strategies, you can ‘treat the treatment’ and use your MS medications reliably and successfully.

Having higher numbers of particular gut microbes might put you at a higher risk of developing multiple sclerosis (MS), a new twin study shows. The finding could lead to new treatments for preventing ...

Multiple sclerosis (MS) is one of the most commonly experienced neurological disorders. MS affects almost one million U.S. adults and over two million people worldwide. MS is two to three times more ...

Having presented new data at last year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting – where the safety and efficacy of Novartis’ Kesimpta ...